Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.5M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
23.9M
-
Shares change
-
-162K
-
Total reported value, excl. options
-
$51.1M
-
Value change
-
-$365K
-
Number of buys
-
12
-
Number of sells
-
-7
-
Price
-
$2.14
Significant Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q3 2023
37 filings reported holding HOWL - Werewolf Therapeutics, Inc. - Common Stock as of Q3 2023.
Werewolf Therapeutics, Inc. - Common Stock (HOWL) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.9M shares
of 48.5M outstanding shares and own 49.23% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6.14M shares), MPM ASSET MANAGEMENT LLC (4.28M shares), PFM Health Sciences, LP (2.56M shares), MPM BIOIMPACT LLC (2.39M shares), Rubric Capital Management LP (1.94M shares), BANK OF AMERICA CORP /DE/ (1.53M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1M shares), SPHERA FUNDS MANAGEMENT LTD. (627K shares), DC Funds, LP (589K shares), and VANGUARD GROUP INC (548K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.